Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 27.53 CNY -2.13% Market Closed
Market Cap: 6.4B CNY
Have any thoughts about
Sirio Pharma Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

15.4
Current
15.6
Median
10.5
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
15.4
=
Enterprise Value
7.3B CNY
/
EBITDA
475.9m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
9.8
2-Years Forward
EV/EBITDA
8.2
3-Years Forward
EV/EBITDA
7.4

See Also

Discover More